-
Does Novartis’s Acquisition of AveXis Spell Trouble for Biogen?
Switzerland-based Novartis is buying Bannockburn, Illinois-based AveXis for $8.7 billion. This could spell big trouble for Cambridge, Massachusetts-ba...
2018-04-11 11:27 -
Nutriband Acquires 4P Therapeutics
Nutriband has acquired 4P Therapeutics for $1.9 million. 4P Therapeutics will now become the pharmaceutical and development arm of Nutriband with a sp...
2018-04-11 11:10 -
Novartis Inks $8.7B Deal to Acquire AveXis
Novartis has entered an agreement to buy AveXis Inc., a gene therapy company, for $8.7 billion dollars as part of its neuroscience strategy.
2018-04-11 11:10 -
LSNE Expands Capabilities and QC Laboratory Space
Lyophilization Services of New England (LSNE) has unveiled a strategic plan to expand its quality control (QC) laboratory in Bedford, NH, and provide ...
2018-04-11 11:10 -
Lonza Opens Cell and Gene Therapy Mfg. Facility
Lonza has opened what it claims to be the world's largest dedicated cell-and-gene-therapy facility located outside the Houston, TX area. The company s...
2018-04-11 11:10 -
BASF 'Creates Chemistry' with Southfield Students through Kids’ Lab Program
Children at McIntyre Elementary School were recently introduced to the basic principles of chemistry and laboratory safety thanks to volunteers from ...
2018-04-11 10:30 -
Phoseon Technology Announces Investment in Factory, Global Business Expansion
Phoseon Technology announced its continued business expansion and growth plan. “The positive investment atmosphere for corporations in the U.S. and...
2018-04-11 10:30 -
PDVSA May Close 3 Refineries
The three refineries include the 305 thousand barrels/day Cardon Refinery, the 140 thousand barrels/day EIPalito Refinery and the 190 th...
2018-04-10 17:05 -
Covestro LLC At The American Coatings Show 2018
Covestro LLC is a leading supplier of coating raw materials with over 75 years of experience in polyurethane chemistry. At the American Coatings Show ...
2018-04-10 16:27 -
Boehringer, OSE Deal Could be Worth More Than $1.1B
Boehringer Ingelheim and OSE Immunotherapeutics have entered a collaboration and exclusive worldwide collaboration and license agreement to jointly de...
2018-04-10 15:19
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
